| Code | 20053 | ||||||||||
| MA number | 16/0362/10-S | ||||||||||
| Product Form: | tbl flm 14x75 mg (blis. Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 08.06.2010 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Clopidogrel Actavis 75 mg_10.2023.pdf
|
| SPC: |
SPC_Clopidogrel Actavis 75 mg_03.2024.pdf
|
| Safety feature | Yes |
| Data update: | 17.04.2018 |
